Guardian Pharmacy Services, Inc.
GRDN Healthcare Medical Care Facilities
Guardian Pharmacy Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 17.9% from fiscal 2024.
- Revenue
- −1.68%
- EPS
- +133.3%
- Free cash flow
- +88.9%
Quarter to September 2026, against a year earlier
Follow GRDN
Alert me
Guardian Pharmacy Services, Inc. (GRDN) Net margin
Guardian Pharmacy Services, Inc.'s net margin over the twelve months to 30 September 2026 was 5.13%, up 1.7 percentage points from fiscal 2025 (3.40%). That is above the Medical Care Facilities industry median of 3.05% and above the Healthcare sector median of 0.00%.
Net margin, annual
Embed this chart
Annual newest first
| Period | Net margin | Change (points) |
|---|---|---|
| FY2025 | 3.40% | 12.36 |
| FY2024 | −8.96% | (8.96) |
| FY2023 | 0.00% | — |
Quarterly newest first
| Period | Net margin | Change (points) |
|---|---|---|
| Sep 2026 | 5.03% | (1.19) |
| Jun 2026 | 6.22% | 2.27 |
| Mar 2026 | 3.95% | (1.31) |
| Dec 2025 | 5.26% | 2.66 |
| 8 more quarters | Free account |
Net margin against peers
| Company | Net margin |
|---|---|
| AVAH Aveanna Healthcare Holdings Inc. compare | 10.6% |
| MD Pediatrix Medical Group, Inc. compare | 7.66% |
| ADUS Addus HomeCare Corporation compare | 7.39% |
| NHC National HealthCare Corporation compare | 7.24% |
| GRDN Guardian Pharmacy Services, Inc. | 5.13% |
| ASTH Astrana Health, Inc. compare | 1.05% |
| SGRY Surgery Partners, Inc. compare | −2.63% |
| BKD Brookdale Senior Living Inc. compare | −4.53% |
| ACHC Acadia Healthcare Company, Inc. compare | −33.1% |
| Medical Care Facilities industry median | 3.05% |
| Healthcare sector median | 0.00% |
| Market median | 1.06% |
What Net margin is
Net Profit Margin tells an investor how much of each unit of revenue ends up as profit for shareholders after all costs, interest and taxes.
Net Income Allotted to Shareholders ÷ Revenue
More on GRDN
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- The full statement